Difference between revisions of "Olfactory neuroblastoma"
Jump to navigation
Jump to search
Jensflorian (talk | contribs) (Molecular Data added) |
Jensflorian (talk | contribs) (→IHC: differences based on mutation status) |
||
| Line 41: | Line 41: | ||
**Small round cells -ve. | **Small round cells -ve. | ||
*[[Neuroendocrine markers]] +ve (CD56, synaptophysin). | *[[Neuroendocrine markers]] +ve (CD56, synaptophysin). | ||
**lower expression of neuroendocrine markers in IDH2 mutant tumors. | |||
Others: | Others: | ||
| Line 46: | Line 47: | ||
*AE1/AE3 usu. -ve (r/o carcinoma). | *AE1/AE3 usu. -ve (r/o carcinoma). | ||
*CAM5.2 usu. -ve -- up to 35% +ve.<ref name=Ref_WMSP41>{{Ref WMSP|41}}</ref> | *CAM5.2 usu. -ve -- up to 35% +ve.<ref name=Ref_WMSP41>{{Ref WMSP|41}}</ref> | ||
**Higher expression of cytokeratins in IDH2 mutant tumors. | |||
==Molecular== | ==Molecular== | ||
Revision as of 06:42, 22 October 2019
Olfactory neuroblastoma, also known as esthesioneuroblastoma, is a rare aggressive tumour of the head and neck.
Neuroblastoma is dealt with in the neuroblastoma article.
General
Epidemiology:[1]
- Prognosis: poor.
- Wide age range with bimodal distribution - teens and 60s.
- No sex predilection.
Clinical presentation:[1]
- Nasal obstruction ~ 70%.
- Epistaxis ~ 50%.
- Anosmia.
- Headache.
Gross
- Arises from olfactory mucosa - upper nasal cavity.[2]
Microscopic
Features:[1]
- Small round (blue) cell tumour with:
- Stippled chromatin.
- High NC ratio.
- +/-Flexner-Wintersteiner rosette - rosette with empty centre (donut hole).
- +/-Fibrillary, eosinophilic material (neuropil-like).[2]
DDx:
- Lymphoma.
- Small cell carcinoma.
- Other small round cell tumours.
- Basaloid squamous carcinoma.[citation needed]
Images:
IHC
- S-100:
- Sustentacular cells +ve.
- Small round cells -ve.
- Neuroendocrine markers +ve (CD56, synaptophysin).
- lower expression of neuroendocrine markers in IDH2 mutant tumors.
Others:
- CD45 -ve (r/o lymphoma).
- AE1/AE3 usu. -ve (r/o carcinoma).
- CAM5.2 usu. -ve -- up to 35% +ve.[2]
- Higher expression of cytokeratins in IDH2 mutant tumors.
Molecular
See also
References
- ↑ 1.0 1.1 1.2 1.3 Thompson, LD. (Sep 2009). "Olfactory neuroblastoma.". Head Neck Pathol 3 (3): 252-9. doi:10.1007/s12105-009-0125-2. PMC 2811627. PMID 20596981. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811627/.
- ↑ 2.0 2.1 2.2 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 41. ISBN 978-0781765275.
- ↑ URL: http://path.upmc.edu/cases/case467.html. Accessed on: 21 January 2012.
- ↑ Capper, D.; Engel, NW.; Stichel, D.; Lechner, M.; Glöss, S.; Schmid, S.; Koelsche, C.; Schrimpf, D. et al. (08 2018). "DNA methylation-based reclassification of olfactory neuroblastoma.". Acta Neuropathol 136 (2): 255-271. doi:10.1007/s00401-018-1854-7. PMID 29730775.
- ↑ Classe, M.; Yao, H.; Mouawad, R.; Creighton, CJ.; Burgess, A.; Allanic, F.; Wassef, M.; Leroy, X. et al. (10 2018). "Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny.". Cell Rep 25 (3): 811-821.e5. doi:10.1016/j.celrep.2018.09.047. PMID 30332658.